نتایج جستجو برای: pharmacoepidemiology

تعداد نتایج: 456  

Journal: :Journal of Clinical Medicine of Kazakhstan 2018

Journal: :Advances in Pharmacoepidemiology & Drug Safety 2012

Journal: :Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku 2009

Journal: :American journal of epidemiology 2014
Jessica J Jalbert Mary Elizabeth Ritchey Xiaojuan Mi Chih-Ying Chen Bradley G Hammill Lesley H Curtis Soko Setoguchi

Medical devices play a vital role in diagnosing, treating, and preventing diseases and are an integral part of the health-care system. Many devices, including implantable medical devices, enter the market through a regulatory pathway that was not designed to assure safety and effectiveness. Several recent studies and high-profile device recalls have demonstrated the need for well-designed, vali...

2018
Xavier Kurz Susana Perez-Gutthann

The European Medicines Agency (EMA) has the responsibility for the scientific evaluation, supervision, and safety monitoring of medicines in the European Union (EU) to ensure that their benefits outweigh their risks. While the roots of medicines' safety monitoring lie in the development of mechanisms for spontaneous reporting of suspected adverse reactions by health‐care professionals and patie...

2009
Wayne A. Ray Cecilia P. Chung Katherine T. Murray

From the Division of Pharmacoepidemiology, Department of Preventive Medicine (W.A.R., K.H.), the Divisions of Rheumatology (C.P.C., C.M.S.), Cardiology (K.T.M.), and Clinical Pharmacology (K.T.M., C.M.S.), Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine; and the Geriatric Research, Education, and Clinical Center, Nashville Veterans Affairs Medical Center (W.A....

2017
Jordi Castellsague Susana Perez‐Gutthann Brian Calingaert Christine Bui Cristina Varas‐Lorenzo Alejandro Arana Alexandra Prados‐Torres Beatriz Poblador‐Plou Francisca Gonzalez‐Rubio Maria Giner‐Soriano Albert Roso‐Llorach Marie Linder Anna Citarella Oliver Scholle Tilo Blenk Edeltraut Garbe

PURPOSE To describe the characteristics of new users of cilostazol in Europe with the aim to support the evaluation of its benefit/risk as used in regular clinical practice before the implementation of labeling changes recommended by the European Medicines Agency. METHODS New users of cilostazol were identified in populations enrolled in five European health automated databases in the UK (The...

2010
Andrew N. Freedman Leah B. Sansbury William D. Figg Arnold L. Potosky Sheila R. Weiss Smith Muin J. Khoury Stefanie A. Nelson Richard M. Weinshilboum Mark J. Ratain Howard L. McLeod Robert S. Epstein Geoffrey S. Ginsburg Richard L. Schilsky Geoffrey Liu David A. Flockhart Cornelia M. Ulrich Robert L. Davis Lawrence J. Lesko Issam Zineh Gurvaneet Randhawa Christine B. Ambrosone Mary V. Relling Nat Rothman Heng Xie Margaret R. Spitz Rachel Ballard-Barbash James H. Doroshow Lori M. Minasian

Recent advances in genomic research have demonstrated a substantial role for genomic factors in predicting response to cancer therapies. Researchers in the fields of cancer pharmacogenomics and pharmacoepidemiology seek to understand why individuals respond differently to drug therapy, in terms of both adverse effects and treatment efficacy. To identify research priorities as well as the resour...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید